Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patientsAbimbola F. Onyia, AbdulRazzaq Oluwagbemiga Lawal, Opeyemi C. De Campos et al.|Cancer Genetics|2025Cited by 2
<sup>1</sup> H NMR-Based Plasma Metabolomics and Machine Learning Reveal Distinct Metabolic Signatures of Breast Cancer in Nigerian WomenAbimbola F. Onyia, Solomon O. Rotimi, Jelili Oyelade et al.|Journal of Proteome Research|2026Cited by 0